PlainRecalls
FDA Drug Low Class III Ongoing

Diflorasone Diacetate Ointment, USP, 0.05%, 60g tube, Rx only, Mfd. By: Lyne Laboratories, Inc., Brockton, MA 02301; Mfd. For: Rising Pharmaceuticals, Inc., East Brunswick, NJ 08816 NDC 64980-124-60

Reported: July 17, 2024 Initiated: June 24, 2024 #D-0599-2024

Product Description

Diflorasone Diacetate Ointment, USP, 0.05%, 60g tube, Rx only, Mfd. By: Lyne Laboratories, Inc., Brockton, MA 02301; Mfd. For: Rising Pharmaceuticals, Inc., East Brunswick, NJ 08816 NDC 64980-124-60

Reason for Recall

Failed Impurities/Degradation Specifications: The impurity results at 12 months stability testing,did not conform to the specification limit.

Details

Units Affected
868 tubes
Distribution
Nationwide in the USA
Location
East Brunswick, NJ

Frequently Asked Questions

What product was recalled?
Diflorasone Diacetate Ointment, USP, 0.05%, 60g tube, Rx only, Mfd. By: Lyne Laboratories, Inc., Brockton, MA 02301; Mfd. For: Rising Pharmaceuticals, Inc., East Brunswick, NJ 08816 NDC 64980-124-60. Recalled by Rising Pharma Holding, Inc.. Units affected: 868 tubes.
Why was this product recalled?
Failed Impurities/Degradation Specifications: The impurity results at 12 months stability testing,did not conform to the specification limit.
Which agency issued this recall?
This recall was issued by the FDA Drug on July 17, 2024. Severity: Low. Recall number: D-0599-2024.